LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe ...
The average glioblastoma patient survives 12–18 months after diagnosis. The crux of the diagnostic is a biochip that uses electrokinetic technology to detect biomarkers, or active Epidermal Growth ...